SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

10 Feb 2024 Evaluate
The Sales for the quarter ended December 2023 of Rs. 388.59 millions rose by 37.97% from Rs. 281.65 millions.A good growth in profit of 32.68% reported to Rs. 130.12  millions over Rs. 98.07 millions of corresponding previous quarter.OP of the company witnessed a marginal growth to 187.49 millions from 139.17 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 388.59 281.65 37.97 1281.01 1208.00 6.04 1489.73 1148.54 29.71
Other Income 10.04 18.06 -44.41 30.80 46.25 -33.41 60.24 40.50 48.74
PBIDT 187.49 139.17 34.72 611.50 639.17 -4.33 802.42 620.96 29.22
Interest 0.79 0.71 11.27 1.55 1.75 -11.43 2.01 8.28 -75.72
PBDT 186.70 138.46 34.84 609.95 637.42 -4.31 800.41 612.68 30.64
Depreciation 9.78 6.58 48.63 26.11 18.07 44.49 25.76 22.33 15.36
PBT 176.92 131.88 34.15 583.84 619.35 -5.73 774.65 590.35 31.22
TAX 46.80 33.81 38.42 151.09 156.58 -3.51 194.96 154.10 26.52
Deferred Tax 0.72 1.77 -59.32 2.79 2.51 11.16 2.55 0.72 254.17
PAT 130.12 98.07 32.68 432.75 462.77 -6.49 579.69 436.25 32.88
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 48.25 49.41 -2.35 47.74 52.91 -9.78 53.86 54.07 -0.37

Guj. Themis Biosyn Share Price

333.15 -1.00 (-0.30%)
21-Apr-2026 11:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1667.50
Dr. Reddys Lab 1221.70
Cipla 1231.85
Zydus Lifesciences 929.50
Lupin 2322.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×